NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 180 filers reported holding NEKTAR THERAPEUTICS in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $300,000 | +23.0% | 24,457 | +37.9% | 0.08% | +128.6% |
Q1 2016 | $244,000 | -61.0% | 17,736 | -52.2% | 0.04% | -47.8% |
Q4 2015 | $625,000 | -81.2% | 37,093 | -86.1% | 0.07% | -79.4% |
Q2 2015 | $3,327,000 | +649.3% | 265,960 | +622.3% | 0.32% | +755.3% |
Q3 2014 | $444,000 | -35.1% | 36,822 | -30.9% | 0.04% | -29.6% |
Q2 2014 | $684,000 | -85.0% | 53,318 | -85.9% | 0.05% | -82.1% |
Q1 2014 | $4,571,000 | +52.5% | 377,155 | +31.4% | 0.30% | +120.4% |
Q3 2013 | $2,998,000 | +28.6% | 287,048 | +42.2% | 0.14% | +39.8% |
Q2 2013 | $2,332,000 | – | 201,929 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |